Diogenx

Developer of a biotechnology platform designed to regenerate insulin-producing beta cells for the treatment of diabetes. The company offers recombinant proteins that modulate the signalling pathway, e...

Healthcare

Marseille, France

Founded 2020

9 employees

Website

Valuation

$21.2M

Market implied

Share Price

N/A

Total Raised

$41.5M

Last Round

N/A

Investors

+10 other investors

View all 10 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Diogenx's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required